KHARE, A.; MANDLOI, V.; SHRIVASTAVA, A.; SHRIVASTAVA, A. K.; WADAGBALKAR, P.; KUMAR, A. Impact of oral palonosetron in improving quality of life as compared to other oral 5-HT3 antagonists in delayed chemotherapy induced nausea and vomiting in patients of head and neck cancer. International Journal of Basic & Clinical Pharmacology, [S. l.], v. 8, n. 3, p. 493–496, 2019. DOI: 10.18203/2319-2003.ijbcp20190653. Disponível em: Acesso em: 22 jun. 2024.